Search alternatives:
loss version » loss aversion, less version, cross version
risk version » risk aversion, disk version, risk session
loss version » loss aversion, less version, cross version
risk version » risk aversion, disk version, risk session
|
by Deonandan, Raywat, Jones, Sarah
Published 2017
“... the intravitreal use of bevacizumab, citing increased risk of ophthalmic complications. In addition...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Deonandan, Raywat, Jones, Sarah
Published 2017
“... the intravitreal use of bevacizumab, citing increased risk of ophthalmic complications. In addition...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Peprah, Kwakye, McCormack, Suzanne
Published 2019
“... of cognitive functions that affects daily activities. Symptoms may include memory loss and difficulties...”Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Peprah, Kwakye, McCormack, Suzanne
Published 2019
“... of cognitive functions that affects daily activities. Symptoms may include memory loss and difficulties...”Published 2019
Canadian Agency for Drugs and Technologies in Health